Literature DB >> 18159414

Outcome of bacteremia and fungemia in paediatric oncology patients.

Joan L Robinson1, Robert P Rennie.   

Abstract

OBJECTIVE: To determine the outcome of paediatric oncology patients with positive blood cultures.
DESIGN: Retrospective chart review.
SETTING: Tertiary care hospital. POPULATION STUDIED: Oncology patients up to 17 years of age with positive blood cultures from January 1, 1994 to March 31, 1999. MAIN
RESULTS: There were 121 episodes of positive blood cultures in 76 patients. Seventeen episodes were excluded because blood cultures were contaminated. Of the organisms grown from the remaining episodes, 63% were Gram-positive organisms, 23% were Gram-negative organisms, 3% were fungal and 11% were mixed. There were 13 episodes with pure or mixed isolates of Staphylococcus aureus, of which nine occurred within 14 days of the placement of a new central venous tunnelled catheter. Central venous tunnelled catheters were retained in 76 of the 102 episodes when they were present. There were two relapses, and four children were admitted to the intensive care unit with septic shock, but all survived.
CONCLUSIONS: The outcome was excellent with the current management of possible bacteremia in paediatric oncology patients, but the high incidence of S aureus bacteremia suggests that empirical antibiotics should be altered if sepsis is suspected within 14 days of the placement of a central venous catheter.

Entities:  

Keywords:  Bacteremia; Empirical antibiotics; Fungemia; Oncology; Paediatric

Year:  2002        PMID: 18159414      PMCID: PMC2094897          DOI: 10.1155/2002/837329

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  7 in total

Review 1.  Guidelines for the management of intravascular catheter-related infections.

Authors:  L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal:  Clin Infect Dis       Date:  2001-04-03       Impact factor: 9.079

Review 2.  Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: pros and cons.

Authors:  R Feld
Journal:  Clin Infect Dis       Date:  1999-09       Impact factor: 9.079

3.  Staphylococcus aureus bacteremia in patients with Hickman catheters.

Authors:  D C Dugdale; P G Ramsey
Journal:  Am J Med       Date:  1990-08       Impact factor: 4.965

4.  Septicemia and septic shock in pediatric patients: 140 consecutive cases on a pediatric hematology-oncology service.

Authors:  A Aledo; G Heller; L Ren; S Gardner; I Dunkel; S W McKay; C Flombaum; A E Brown
Journal:  J Pediatr Hematol Oncol       Date:  1998 May-Jun       Impact factor: 1.289

5.  Infectious risks of Broviac catheters in children with neoplastic diseases: a matched pairs analysis.

Authors:  D Harms; I Görtitz; W Lambrecht; H Kabisch; R Erttmann; G Janka-Schaub
Journal:  Pediatr Infect Dis J       Date:  1992-12       Impact factor: 2.129

6.  Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients.

Authors:  M H Gorelick; W C Owen; N L Seibel; G H Reaman
Journal:  Pediatr Infect Dis J       Date:  1991-07       Impact factor: 2.129

7.  The changing epidemiology of bacteremia in neutropenic children with cancer.

Authors:  V M Aquino; A Pappo; G R Buchanan; I Tkaczewski; M M Mustafa
Journal:  Pediatr Infect Dis J       Date:  1995-02       Impact factor: 2.129

  7 in total
  2 in total

1.  Practical approach to catheter-related bloodstream infections in paediatrics.

Authors:  Joan Robinson
Journal:  Paediatr Child Health       Date:  2005-10       Impact factor: 2.253

Review 2.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.